Global Tuberculosis Prevention and Treatment Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 102

Published Date: 05 Jul 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Tuberculosis Prevention and Treatment Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Tuberculosis Prevention and Treatment Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Tuberculosis Prevention and Treatment Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Tuberculosis Prevention and Treatment Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Immune Vaccine
    Therapy Vaccine

Market segment by Application can be divided into
    Self-Procurement
    UNICEF
    Other

The key market players for global Tuberculosis Prevention and Treatment Vaccine market are listed below:
    Merck
    Japan BCG Lab
    Serum Institute of India
    AJ Vaccines
    BioFarma
    GreenSignal Bio Pharma
    China National Biotec
    Biomed Lublin
    Taj Pharmaceuticals
    Ataulpho de Paiva
    IVAC
    Queen Saovabha Mem. Inst
    Microgen

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Tuberculosis Prevention and Treatment Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tuberculosis Prevention and Treatment Vaccine, with price, sales, revenue and global market share of Tuberculosis Prevention and Treatment Vaccine from 2019 to 2021.
Chapter 3, the Tuberculosis Prevention and Treatment Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Prevention and Treatment Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Tuberculosis Prevention and Treatment Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Tuberculosis Prevention and Treatment Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Tuberculosis Prevention and Treatment Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Immune Vaccine
        1.2.3 Therapy Vaccine
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Self-Procurement
        1.3.3 UNICEF
        1.3.4 Other
    1.4 Global Tuberculosis Prevention and Treatment Vaccine Market Size & Forecast
        1.4.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Value (2016-2026))
        1.4.2 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume (2016-2026)
        1.4.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity Analysis
        1.5.1 Global Tuberculosis Prevention and Treatment Vaccine Total Production Capacity (2016-2026)
        1.5.2 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Tuberculosis Prevention and Treatment Vaccine Market Drivers
        1.6.2 Tuberculosis Prevention and Treatment Vaccine Market Restraints
        1.6.3 Tuberculosis Prevention and Treatment Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Japan BCG Lab
        2.2.1 Japan BCG Lab Details
        2.2.2 Japan BCG Lab Major Business
        2.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Serum Institute of India
        2.3.1 Serum Institute of India Details
        2.3.2 Serum Institute of India Major Business
        2.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 AJ Vaccines
        2.4.1 AJ Vaccines Details
        2.4.2 AJ Vaccines Major Business
        2.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 BioFarma
        2.5.1 BioFarma Details
        2.5.2 BioFarma Major Business
        2.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 GreenSignal Bio Pharma
        2.6.1 GreenSignal Bio Pharma Details
        2.6.2 GreenSignal Bio Pharma Major Business
        2.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 China National Biotec
        2.7.1 China National Biotec Details
        2.7.2 China National Biotec Major Business
        2.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.7.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Biomed Lublin
        2.8.1 Biomed Lublin Details
        2.8.2 Biomed Lublin Major Business
        2.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Taj Pharmaceuticals
        2.9.1 Taj Pharmaceuticals Details
        2.9.2 Taj Pharmaceuticals Major Business
        2.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Ataulpho de Paiva
        2.10.1 Ataulpho de Paiva Details
        2.10.2 Ataulpho de Paiva Major Business
        2.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 IVAC
        2.11.1 IVAC Details
        2.11.2 IVAC Major Business
        2.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Queen Saovabha Mem. Inst
        2.12.1 Queen Saovabha Mem. Inst Details
        2.12.2 Queen Saovabha Mem. Inst Major Business
        2.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Microgen
        2.13.1 Microgen Details
        2.13.2 Microgen Major Business
        2.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Tuberculosis Prevention and Treatment Vaccine Sales by Manufacturer
    3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Tuberculosis Prevention and Treatment Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Tuberculosis Prevention and Treatment Vaccine Manufacturer Market Share
        3.4.2 Top 6 Tuberculosis Prevention and Treatment Vaccine Manufacturer Market Share
    3.5 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Tuberculosis Prevention and Treatment Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region
        4.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Region (2016-2026)
        4.1.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2026)
    4.2 North America Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)
    4.3 Europe Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)
    4.4 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)
    4.5 South America Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)
    4.6 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Type (2016-2026)
    5.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2016-2026)
    5.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Application (2016-2026)
    6.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2016-2026)
    6.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)
    7.2 North America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)
    7.3 North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country
        7.3.1 North America Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Country (2016-2026)
        7.3.2 North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)
    8.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)
    8.3 Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country
        8.3.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Country (2016-2026)
        8.3.2 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)
    9.2 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)
    9.3 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region
        9.3.1 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)
    10.2 South America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)
    10.3 South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country
        10.3.1 South America Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Country (2016-2026)
        10.3.2 South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)
    11.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)
    11.3 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Country
        11.3.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Tuberculosis Prevention and Treatment Vaccine Typical Distributors
    12.3 Tuberculosis Prevention and Treatment Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application, (USD Million), 2021-2026
    Table 3. Merck Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Major Business
    Table 5. Merck Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 6. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
    Table 8. Japan BCG Lab Major Business
    Table 9. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 10. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Serum Institute of India Basic Information, Manufacturing Base and Competitors
    Table 12. Serum Institute of India Major Business
    Table 13. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 14. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. AJ Vaccines Basic Information, Manufacturing Base and Competitors
    Table 16. AJ Vaccines Major Business
    Table 17. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 18. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. BioFarma Basic Information, Manufacturing Base and Competitors
    Table 20. BioFarma Major Business
    Table 21. BioFarma Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 22. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
    Table 24. GreenSignal Bio Pharma Major Business
    Table 25. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 26. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. China National Biotec Basic Information, Manufacturing Base and Competitors
    Table 28. China National Biotec Major Business
    Table 29. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 30. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Biomed Lublin Basic Information, Manufacturing Base and Competitors
    Table 32. Biomed Lublin Major Business
    Table 33. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 34. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 36. Taj Pharmaceuticals Major Business
    Table 37. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 38. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
    Table 40. Ataulpho de Paiva Major Business
    Table 41. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 42. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. IVAC Basic Information, Manufacturing Base and Competitors
    Table 44. IVAC Major Business
    Table 45. IVAC Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 46. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
    Table 48. Queen Saovabha Mem. Inst Major Business
    Table 49. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 50. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. Microgen Basic Information, Manufacturing Base and Competitors
    Table 52. Microgen Major Business
    Table 53. Microgen Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 54. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 55. Global Tuberculosis Prevention and Treatment Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
    Table 56. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 57. Market Position of Manufacturers in Tuberculosis Prevention and Treatment Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 58. Global Tuberculosis Prevention and Treatment Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
    Table 59. Head Office and Tuberculosis Prevention and Treatment Vaccine Production Site of Key Manufacturer
    Table 60. Tuberculosis Prevention and Treatment Vaccine New Entrant and Capacity Expansion Plans
    Table 61. Tuberculosis Prevention and Treatment Vaccine Mergers & Acquisitions in the Past Five Years
    Table 62. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 63. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2021-2026) & (K Units)
    Table 64. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 65. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 66. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 67. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)
    Table 68. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2016-2021e) & (USD Million)
    Table 69. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2021-2026) & (USD Million)
    Table 70. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2021e) & (US$/Unit)
    Table 71. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2021-2026) & (US$/Unit)
    Table 72. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 73. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)
    Table 74. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2016-2021e) & (USD Million)
    Table 75. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2021-2026) & (USD Million)
    Table 76. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2016-2021e) & (US$/Unit)
    Table 77. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2021-2026) & (US$/Unit)
    Table 78. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 79. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units)
    Table 80. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 81. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 82. North America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 83. North America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)
    Table 84. North America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 85. North America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)
    Table 86. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 87. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units)
    Table 88. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 89. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 90. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 91. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)
    Table 92. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 93. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)
    Table 94. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 95. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2021-2026) & (K Units)
    Table 96. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 97. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 98. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 99. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)
    Table 100. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 101. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)
    Table 102. South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 103. South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units)
    Table 104. South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 105. South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 106. South America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 107. South America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)
    Table 108. South America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 109. South America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)
    Table 110. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 111. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units)
    Table 112. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 113. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 114. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 115. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)
    Table 116. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 117. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)
    Table 118. Direct Channel Pros & Cons
    Table 119. Indirect Channel Pros & Cons
    Table 120. Tuberculosis Prevention and Treatment Vaccine Typical Distributors
    Table 121. Tuberculosis Prevention and Treatment Vaccine Typical Customers
List of Figures
    Figure 1. Tuberculosis Prevention and Treatment Vaccine Picture
    Figure 2. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type in 2020
    Figure 3. Immune Vaccine
    Figure 4. Therapy Vaccine
    Figure 5. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application in 2020
    Figure 6. Self-Procurement
    Figure 7. UNICEF
    Figure 8. Other
    Figure 9. Global Tuberculosis Prevention and Treatment Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 10. Global Tuberculosis Prevention and Treatment Vaccine Market Size and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Sales (2016-2026) & (K Units)
    Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 13. Global Tuberculosis Prevention and Treatment Vaccine Production Capacity (2016-2026) & (K Units)
    Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Production Capacity by Geographic Region: 2020 VS 2021
    Figure 15. Tuberculosis Prevention and Treatment Vaccine Market Drivers
    Figure 16. Tuberculosis Prevention and Treatment Vaccine Market Restraints
    Figure 17. Tuberculosis Prevention and Treatment Vaccine Market Trends
    Figure 18. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturer in 2020
    Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Manufacturer in 2020
    Figure 20. Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 21. Top 3 Tuberculosis Prevention and Treatment Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 22. Top 6 Tuberculosis Prevention and Treatment Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 23. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2026)
    Figure 24. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2016-2026)
    Figure 25. North America Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)
    Figure 26. Europe Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)
    Figure 27. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)
    Figure 28. South America Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)
    Figure 29. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)
    Figure 30. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)
    Figure 31. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2016-2026)
    Figure 32. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 33. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)
    Figure 34. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2016-2026)
    Figure 35. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2016-2026) & (US$/Unit)
    Figure 36. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)
    Figure 37. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)
    Figure 38. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2026)
    Figure 39. North America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2026)
    Figure 40. United States Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Canada Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)
    Figure 44. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)
    Figure 45. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2026)
    Figure 46. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2026)
    Figure 47. Germany Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. France Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. United Kingdom Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Russia Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Italy Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2026)
    Figure 53. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)
    Figure 54. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2026)
    Figure 55. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2016-2026)
    Figure 56. China Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Japan Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Korea Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. India Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Australia Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)
    Figure 63. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)
    Figure 64. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2026)
    Figure 65. South America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2026)
    Figure 66. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Argentina Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)
    Figure 69. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)
    Figure 70. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2026)
    Figure 71. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Egypt Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. South Africa Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Sales Channel: Direct Channel vs Indirect Channel
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen

Related Reports

Global Tuberculosis Prevention and Treatment Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Tuberculosis Prevention and Treatment Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 17 Jan 2022

date Pharma & Healthcare

The Tuberculosis Prevention and Treatment Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

tuberculosis prevention treatment vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>